JP2012130342A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012130342A5 JP2012130342A5 JP2012009515A JP2012009515A JP2012130342A5 JP 2012130342 A5 JP2012130342 A5 JP 2012130342A5 JP 2012009515 A JP2012009515 A JP 2012009515A JP 2012009515 A JP2012009515 A JP 2012009515A JP 2012130342 A5 JP2012130342 A5 JP 2012130342A5
- Authority
- JP
- Japan
- Prior art keywords
- side region
- nucleic acid
- acid molecule
- stranded rna
- bases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 39
- 230000014509 gene expression Effects 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 14
- 230000001629 suppression Effects 0.000 claims description 10
- 230000009368 gene silencing by RNA Effects 0.000 claims description 4
- 125000003729 nucleotide group Chemical group 0.000 claims 14
- 108090000623 proteins and genes Proteins 0.000 claims 7
- 230000001939 inductive effect Effects 0.000 claims 4
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 claims 3
- 238000000338 in vitro Methods 0.000 claims 3
- 230000000295 complement effect Effects 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 238000002372 labelling Methods 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 239000002585 base Substances 0.000 description 4
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
- 108091092195 Intron Proteins 0.000 description 1
- 108091030071 RNAI Proteins 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 230000030279 gene silencing Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012009515A JP5804642B2 (ja) | 2010-07-08 | 2012-01-20 | 遺伝子発現制御のための一本鎖核酸分子 |
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010156122 | 2010-07-08 | ||
| JP2010156122 | 2010-07-08 | ||
| JP2010174915 | 2010-08-03 | ||
| JP2010174915 | 2010-08-03 | ||
| JP2010230806 | 2010-10-13 | ||
| JP2010230808 | 2010-10-13 | ||
| JP2010230806 | 2010-10-13 | ||
| JP2010230808 | 2010-10-13 | ||
| JP2010269824 | 2010-12-02 | ||
| JP2010269823 | 2010-12-02 | ||
| JP2010269823 | 2010-12-02 | ||
| JP2010269824 | 2010-12-02 | ||
| JP2012009515A JP5804642B2 (ja) | 2010-07-08 | 2012-01-20 | 遺伝子発現制御のための一本鎖核酸分子 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011537086A Division JP4968811B2 (ja) | 2010-07-08 | 2011-07-08 | 遺伝子発現制御のための一本鎖核酸分子 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015150156A Division JP6162182B2 (ja) | 2010-07-08 | 2015-07-29 | 遺伝子発現制御のための一本鎖核酸分子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012130342A JP2012130342A (ja) | 2012-07-12 |
| JP2012130342A5 true JP2012130342A5 (OSRAM) | 2013-10-03 |
| JP5804642B2 JP5804642B2 (ja) | 2015-11-04 |
Family
ID=45441339
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011537086A Expired - Fee Related JP4968811B2 (ja) | 2010-07-08 | 2011-07-08 | 遺伝子発現制御のための一本鎖核酸分子 |
| JP2012009515A Expired - Fee Related JP5804642B2 (ja) | 2010-07-08 | 2012-01-20 | 遺伝子発現制御のための一本鎖核酸分子 |
| JP2015150156A Expired - Fee Related JP6162182B2 (ja) | 2010-07-08 | 2015-07-29 | 遺伝子発現制御のための一本鎖核酸分子 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011537086A Expired - Fee Related JP4968811B2 (ja) | 2010-07-08 | 2011-07-08 | 遺伝子発現制御のための一本鎖核酸分子 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015150156A Expired - Fee Related JP6162182B2 (ja) | 2010-07-08 | 2015-07-29 | 遺伝子発現制御のための一本鎖核酸分子 |
Country Status (17)
| Country | Link |
|---|---|
| EP (2) | EP2431466B1 (OSRAM) |
| JP (3) | JP4968811B2 (OSRAM) |
| KR (1) | KR101849798B1 (OSRAM) |
| CN (2) | CN104818276B (OSRAM) |
| AU (1) | AU2011274854B2 (OSRAM) |
| BR (1) | BR112013000481A2 (OSRAM) |
| CA (1) | CA2804511C (OSRAM) |
| DK (2) | DK2933333T3 (OSRAM) |
| ES (2) | ES2670017T3 (OSRAM) |
| HU (2) | HUE037500T2 (OSRAM) |
| MX (1) | MX352568B (OSRAM) |
| NZ (2) | NZ704812A (OSRAM) |
| PT (2) | PT2933333T (OSRAM) |
| RU (1) | RU2628311C2 (OSRAM) |
| SG (2) | SG186899A1 (OSRAM) |
| TW (2) | TWI573870B (OSRAM) |
| WO (1) | WO2012005368A1 (OSRAM) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8691782B2 (en) | 2010-08-03 | 2014-04-08 | Bonac Corporation | Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton |
| WO2013077446A1 (ja) * | 2011-11-26 | 2013-05-30 | 株式会社ボナック | 遺伝子発現制御のための一本鎖核酸分子 |
| WO2013133393A1 (ja) * | 2012-03-07 | 2013-09-12 | 学校法人東京医科大学 | Ｖｅｇｆ遺伝子の発現抑制用一本鎖核酸分子 |
| US20150105442A1 (en) * | 2012-03-29 | 2015-04-16 | Aqua Therapeutics Co., Ltd. | Nucleic Acid Molecule Capable of Inhibiting Expression of Periostin Gene, method for Inhibiting Expression of Periostin Gene, and Use of Said Nucleic Acid Molecule |
| CN109810977A (zh) | 2012-05-26 | 2019-05-28 | 株式会社博纳克 | 具有递送功能的基因表达调控用单链核酸分子 |
| EP3088524A4 (en) | 2013-12-26 | 2017-08-09 | Tokyo Medical University | Artificial mimic mirna for controlling gene expression, and use of same |
| CA2935022A1 (en) | 2013-12-27 | 2015-07-02 | Bonac Corporation | Artificial match-type mirna for controlling gene expression and use therefor |
| US10337009B2 (en) | 2014-12-15 | 2019-07-02 | Bonac Corporation | Single-stranded nucleic acid molecule for inhibiting TGF-β1 expression |
| AU2015368293B2 (en) | 2014-12-27 | 2021-07-22 | Bonac Corporation | Naturally occuring miRNA for controlling gene expression, and use of same |
| EP3276003B1 (en) | 2015-03-27 | 2022-07-20 | Bonac Corporation | Single-chain nucleic acid molecule having delivery function and gene expression control ability |
| AU2016346703B2 (en) | 2015-10-30 | 2020-07-02 | Hirofumi Takeuchi | Composition stably containing single-stranded nucleic acid molecule that suppresses expression of TGF-β1 gene |
| HK1259060A1 (en) * | 2015-12-29 | 2019-11-22 | 国立大学法人北海道大学 | Single-stranded nucleic acid molecule inhibiting expression of prorenin gene or prorenin receptor gene, and use thereof |
| JP6800171B2 (ja) | 2016-01-30 | 2020-12-16 | 株式会社ボナック | 人工単一ガイドｒｎａ及びその用途 |
| JPWO2018182008A1 (ja) | 2017-03-31 | 2020-02-06 | 株式会社ボナック | 遺伝子発現制御機能を有する環状型核酸分子 |
| JPWO2018199338A1 (ja) * | 2017-04-27 | 2020-03-12 | 国立大学法人広島大学 | Ｂ型肝炎治療用核酸分子 |
| AU2018307897B2 (en) | 2017-07-28 | 2024-01-25 | Kyorin Pharmaceutical Co., Ltd. | Therapeutic agent for fibrosis |
| WO2019051563A1 (en) | 2017-09-15 | 2019-03-21 | Commonwealth Scientific And Industrial Research Organisation | Rna molecules |
| JP7208911B2 (ja) | 2017-10-11 | 2023-01-19 | 日東電工株式会社 | 核酸分子発現の調節 |
| JPWO2019074110A1 (ja) * | 2017-10-13 | 2020-12-24 | 株式会社ボナック | 一本鎖核酸分子およびその製造方法 |
| TWI830718B (zh) * | 2018-02-09 | 2024-02-01 | 日商住友化學股份有限公司 | 核酸分子之製造方法 |
| US20210115485A1 (en) * | 2018-03-30 | 2021-04-22 | Sumitomo Chemical Company, Limited | Method for producing single-strand rna |
| RU2020130258A (ru) | 2018-03-30 | 2022-05-04 | Торэй Индастриз, Инк. | Способ получения шпилечной одноцепочечной молекулы рнк |
| ES2981806T3 (es) | 2018-10-02 | 2024-10-10 | Toray Industries | Método para producir moléculas de ARN monocatenario en horquilla |
| EP3915567A4 (en) | 2019-01-25 | 2022-09-21 | Kyorin Pharmaceutical Co., Ltd. | Therapeutic agent for fibrosis |
| EP4043473A4 (en) | 2019-10-11 | 2024-03-27 | Sumitomo Chemical Company, Limited | Method for producing nucleic acid oligomers |
| CN115003680B (zh) | 2020-01-29 | 2025-01-28 | 住友化学株式会社 | 制备核酸寡聚物的方法 |
| JP7777452B2 (ja) | 2020-01-29 | 2025-11-28 | 住友化学株式会社 | 核酸オリゴマーの製造方法 |
| JP7613130B2 (ja) | 2020-03-25 | 2025-01-15 | 味の素株式会社 | リガーゼ変異体 |
| KR20220160010A (ko) | 2020-03-27 | 2022-12-05 | 스미또모 가가꾸 가부시끼가이샤 | 핵산 올리고머의 제조 방법 |
| KR20230034969A (ko) | 2020-07-09 | 2023-03-10 | 스미또모 가가꾸 가부시끼가이샤 | 핵산 올리고머의 제조 방법 |
| KR20230074205A (ko) | 2020-09-24 | 2023-05-26 | 스미또모 가가꾸 가부시끼가이샤 | 핵산 올리고머의 제조 방법 |
| EP4410770A1 (en) | 2021-09-28 | 2024-08-07 | Sumitomo Chemical Company, Limited | Production method for purified dichloroacetic acid |
| JPWO2023182274A1 (OSRAM) | 2022-03-23 | 2023-09-28 | ||
| JP7201190B1 (ja) | 2022-06-03 | 2023-01-10 | 株式会社セツロテック | 遺伝子改変動物由来の動物繊維 |
| EP4477659A4 (en) | 2022-10-27 | 2025-07-30 | Sumitomo Chemical Co | METHOD FOR PRODUCING AN OLIGONUCLEOTIDE |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3687808A (en) | 1969-08-14 | 1972-08-29 | Univ Leland Stanford Junior | Synthetic polynucleotides |
| US5631148A (en) * | 1994-04-22 | 1997-05-20 | Chiron Corporation | Ribozymes with product ejection by strand displacement |
| US6509323B1 (en) | 1998-07-01 | 2003-01-21 | California Institute Of Technology | Linear cyclodextrin copolymers |
| FR2790757B1 (fr) * | 1999-03-09 | 2003-08-01 | Bioalliance Pharma | Oligonucleotides contenant une sequence antisens stabilises par une structure secondaire et compositions pharmaceutiques les contenant. |
| TWI321054B (en) | 2000-12-19 | 2010-03-01 | California Inst Of Techn | Compositions containing inclusion complexes |
| AU2003219900A1 (en) * | 2002-02-22 | 2003-09-09 | James R. Eshleman | Antigene locks and therapeutic uses thereof |
| DK1527176T4 (en) * | 2002-08-05 | 2017-07-03 | Silence Therapeutics Gmbh | ADDITIONAL NEW FORMS OF INTERFERRING RNA MOLECULES |
| US20040058886A1 (en) * | 2002-08-08 | 2004-03-25 | Dharmacon, Inc. | Short interfering RNAs having a hairpin structure containing a non-nucleotide loop |
| ATE532865T1 (de) * | 2003-09-30 | 2011-11-15 | Anges Mg Inc | Klammerartiges oligonukleotid und dieses enthaltender arzneistoff |
| EP1789553B1 (en) * | 2004-06-30 | 2014-03-26 | Alnylam Pharmaceuticals Inc. | Oligonucleotides comprising a non-phosphate backbone linkage |
| BRPI0519690A2 (pt) * | 2004-12-30 | 2009-03-03 | Todd M Hauser | composiÇÕes e mÉtodos para modular a expressço de genes usando oligonucleotÍdeos autoprotegidos |
| WO2007108621A1 (en) * | 2006-03-17 | 2007-09-27 | Bioneer Corporation | Sirna for inhibiting nf-kb/rela expression |
| JP5296328B2 (ja) * | 2007-05-09 | 2013-09-25 | 独立行政法人理化学研究所 | １本鎖環状ｒｎａおよびその製造方法 |
| JP2011504730A (ja) * | 2007-11-29 | 2011-02-17 | 蘇州瑞博生物技術有限公司 | 標的遺伝子の発現を干渉する複合体分子およびその合成方法 |
| US20110159586A1 (en) * | 2007-12-07 | 2011-06-30 | Halo-Bio Rnai Therapeutics, Inc. | Compositions and methods for modulating gene expression using asymmetrically-active precursor polynucleotides |
| EP2256191A4 (en) * | 2008-02-15 | 2011-07-06 | Riken | CYCLIC SINGLE NUCLEIC ACID COMPLEX AND METHOD FOR THE PRODUCTION THEREOF |
| JP5187580B2 (ja) | 2008-12-26 | 2013-04-24 | 丸紅建材リース株式会社 | 掘削機の泥土飛散防止装置 |
| JP2010174915A (ja) | 2009-01-27 | 2010-08-12 | Toyota Motor Corp | 高圧ガスタンク |
| JP5449815B2 (ja) | 2009-03-26 | 2014-03-19 | 住友化学株式会社 | 偏光板の製造方法 |
| JP5233790B2 (ja) | 2009-03-26 | 2013-07-10 | 船井電機株式会社 | 液晶モジュール |
| JP4885255B2 (ja) | 2009-05-21 | 2012-02-29 | 株式会社エフピコ | 包装用容器 |
| JP2010269823A (ja) | 2009-05-21 | 2010-12-02 | British American Tobacco Japan Kk | 喫煙品用容器 |
-
2011
- 2011-07-08 SG SG2013000211A patent/SG186899A1/en unknown
- 2011-07-08 PT PT151699337T patent/PT2933333T/pt unknown
- 2011-07-08 CA CA2804511A patent/CA2804511C/en active Active
- 2011-07-08 NZ NZ704812A patent/NZ704812A/en unknown
- 2011-07-08 ES ES15169933.7T patent/ES2670017T3/es active Active
- 2011-07-08 EP EP11746147.5A patent/EP2431466B1/en active Active
- 2011-07-08 NZ NZ606232A patent/NZ606232A/en not_active IP Right Cessation
- 2011-07-08 TW TW104143857A patent/TWI573870B/zh active
- 2011-07-08 DK DK15169933.7T patent/DK2933333T3/en active
- 2011-07-08 HU HUE15169933A patent/HUE037500T2/hu unknown
- 2011-07-08 HU HUE11746147A patent/HUE026520T2/en unknown
- 2011-07-08 AU AU2011274854A patent/AU2011274854B2/en active Active
- 2011-07-08 CN CN201510226685.6A patent/CN104818276B/zh not_active Expired - Fee Related
- 2011-07-08 WO PCT/JP2011/065737 patent/WO2012005368A1/ja not_active Ceased
- 2011-07-08 TW TW100124393A patent/TWI527901B/zh not_active IP Right Cessation
- 2011-07-08 SG SG2013097233A patent/SG196779A1/en unknown
- 2011-07-08 RU RU2013105329A patent/RU2628311C2/ru active
- 2011-07-08 MX MX2013000315A patent/MX352568B/es active IP Right Grant
- 2011-07-08 KR KR1020127033429A patent/KR101849798B1/ko active Active
- 2011-07-08 BR BR112013000481-9A patent/BR112013000481A2/pt not_active Application Discontinuation
- 2011-07-08 ES ES11746147.5T patent/ES2550487T3/es active Active
- 2011-07-08 CN CN201180027223.1A patent/CN102918156B/zh not_active Expired - Fee Related
- 2011-07-08 EP EP15169933.7A patent/EP2933333B1/en active Active
- 2011-07-08 PT PT117461475T patent/PT2431466E/pt unknown
- 2011-07-08 DK DK11746147.5T patent/DK2431466T3/en active
- 2011-07-08 JP JP2011537086A patent/JP4968811B2/ja not_active Expired - Fee Related
-
2012
- 2012-01-20 JP JP2012009515A patent/JP5804642B2/ja not_active Expired - Fee Related
-
2015
- 2015-07-29 JP JP2015150156A patent/JP6162182B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012130342A5 (OSRAM) | ||
| US12486505B2 (en) | Oligonucleotide compositions and methods thereof | |
| US20240117347A1 (en) | Oligonucleotide compositions and methods thereof | |
| Bhatti et al. | Emerging role of non‐coding RNA in health and disease | |
| US10724035B2 (en) | Oligonucleotide compositions and methods thereof | |
| Van Rooij et al. | MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles | |
| Kesy et al. | A short chemically modified dsRNA-binding PNA (dbPNA) inhibits influenza viral replication by targeting viral RNA panhandle structure | |
| JP2012029693A5 (OSRAM) | ||
| RU2013105329A (ru) | Молекула одноцепочечной нуклеиновой кислоты для контроля экспрессии генов | |
| JP2009159971A5 (OSRAM) | ||
| WO2020191212A1 (en) | Antisense oligonucleotide-based progranulin augmentation therapy in neurodegenerative diseases | |
| JP2009219504A5 (OSRAM) | ||
| JP2012506254A5 (OSRAM) | ||
| JP2012050449A5 (OSRAM) | ||
| JP2013510561A5 (OSRAM) | ||
| JP2011500858A5 (OSRAM) | ||
| JP2012516856A5 (OSRAM) | ||
| JP2013537404A5 (OSRAM) | ||
| Han et al. | Programmable siRNA pro-drugs that activate RNAi activity in response to specific cellular RNA biomarkers | |
| Baud et al. | Partners in crime: Proteins implicated in RNA repeat expansion diseases | |
| Liang et al. | Ring-structured DNA and RNA as key players in vivo and in vitro | |
| Sharma et al. | Engineering circular RNA for molecular and metabolic reprogramming | |
| JP2012085645A5 (OSRAM) | ||
| KR102131883B1 (ko) | Cre 재조합효소 의존적으로 TREK-1 발현이 억제되는 항우울 동물모델 및 이의 제조방법 | |
| Gambari | The role of OMICS research in understanding phenotype variation in thalassaemia: the THALAMOSS project |